Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Orosz

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|September 20, 1991
Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulinK Liliom, F Orosz, L Horváth, et al.
Biochemistry|February 23, 1999
Phosphofructokinase from Dictyostelium discoideum is a potent inhibitor of tubulin polymerizationF Orosz, B Santamaría, J Ovádi, et al.
The Journal of Biological Chemistry|November 5, 1997
Alternative binding of two sequential glycolytic enzymes to microtubules. Molecular studies in the phosphofructokinase/aldolase/microtubule systemB G Vértessy, F Orosz, J Kovács, et al.
FEBS Letters|December 6, 2001
Tubulin and microtubule are potential targets for brain hexokinase bindingG Wágner, J Kovács, P Löw, et al.
Cytoskeleton (Hoboken, N.J.)|September 17, 2013
Moonlighting microtubule-associated proteins: regulatory functions by day and pathological functions at nightJ Oláh, N Tőkési, A Lehotzky, et al.
European Journal of Pharmacology|October 15, 1995
Anti-calmodulin potency of indol alkaloids in in vitro systemsA Molnár, K Liliom, F Orosz, et al.
Journal of Theoretical Biology|October 7, 1996
Triosephosphate isomerase deficiency: predictions and factsF Orosz, B G Vértessy, S Hollán, et al.
The Biochemical Journal|June 15, 1992
Effects of calmodulin antagonists on antibody binding to calmodulin. Distinct conformers of calmodulin induced by the binding of drugsF Orosz, K Liliom, N A Barkhudaryan, et al.
Molecular Pharmacology|December 1, 1990
Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysisF Orosz, M Telegdi, K Liliom, et al.
British Journal of Pharmacology|July 1, 1997
The interaction of a new anti-tumour drug, KAR-2 with calmodulinF Orosz, B G Vértessy, C Salerno, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|September 20, 1991
Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulinK Liliom, F Orosz, L Horváth, et al.
Biochemistry|February 23, 1999
Phosphofructokinase from Dictyostelium discoideum is a potent inhibitor of tubulin polymerizationF Orosz, B Santamaría, J Ovádi, et al.
The Journal of Biological Chemistry|November 5, 1997
Alternative binding of two sequential glycolytic enzymes to microtubules. Molecular studies in the phosphofructokinase/aldolase/microtubule systemB G Vértessy, F Orosz, J Kovács, et al.
FEBS Letters|December 6, 2001
Tubulin and microtubule are potential targets for brain hexokinase bindingG Wágner, J Kovács, P Löw, et al.
Cytoskeleton (Hoboken, N.J.)|September 17, 2013
Moonlighting microtubule-associated proteins: regulatory functions by day and pathological functions at nightJ Oláh, N Tőkési, A Lehotzky, et al.
European Journal of Pharmacology|October 15, 1995
Anti-calmodulin potency of indol alkaloids in in vitro systemsA Molnár, K Liliom, F Orosz, et al.
Journal of Theoretical Biology|October 7, 1996
Triosephosphate isomerase deficiency: predictions and factsF Orosz, B G Vértessy, S Hollán, et al.
The Biochemical Journal|June 15, 1992
Effects of calmodulin antagonists on antibody binding to calmodulin. Distinct conformers of calmodulin induced by the binding of drugsF Orosz, K Liliom, N A Barkhudaryan, et al.
Molecular Pharmacology|December 1, 1990
Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysisF Orosz, M Telegdi, K Liliom, et al.
British Journal of Pharmacology|July 1, 1997
The interaction of a new anti-tumour drug, KAR-2 with calmodulinF Orosz, B G Vértessy, C Salerno, et al.
Pageof 4